Diagnosis and treatment of erectile dysfunction.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing epidemiological data and clinical algorithms without systematic review methods.
PubMed 11137497 · doi:10.1016/s0002-9343(00)00655-0
What was done
This narrative review synthesizes epidemiology, etiology, comorbidities, and diagnostic and management algorithms for erectile dysfunction (ED), citing data from sources such as the Massachusetts Male Aging Study (MMAS).
What was found
Up to 30 million men in the United States have ED. In the MMAS, 52% of men aged 40 to 70 years exhibited some degree of ED, with risk increasing significantly with age. The review notes that most cases are primarily organic and vascular, with psychological factors often contributing. ED is associated with reduced quality of life, depression, anxiety, diabetes, hypertension, and cardiovascular disease. A goal-directed evaluation algorithm tailored to patient and partner treatment preferences was introduced to simplify primary care management and the application of oral or other therapies.
Why it matters
It highlights the need for routine sexual history screening in primary care, positioning ED both as a quality-of-life condition and as a marker of occult cardiovascular or metabolic pathology.
Limits
This is a non-systematic narrative review providing no detailed search methods, inclusion criteria, or risk-of-bias assessments. Specific quantitative diagnostic test accuracies and comparative treatment effect sizes are omitted from the abstract.
Cited by
- supports There are approximately 30 million men with erectile dysfunction in the United States.